Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Rises By 53.5%

Cosmos Health Inc. (NASDAQ:COSM) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 537,800 shares, an increase of 53.5% from the December 15th total of 350,300 shares. Currently, 2.9% of the shares of the company are sold short. Based on an average daily trading volume, of 219,100 shares, the short-interest ratio is presently 2.5 days.

Cosmos Health Price Performance

Shares of NASDAQ COSM traded up $0.02 during mid-day trading on Friday, reaching $0.86. 452,441 shares of the company traded hands, compared to its average volume of 464,086. Cosmos Health has a fifty-two week low of $0.47 and a fifty-two week high of $1.58. The firm has a market cap of $19.94 million, a PE ratio of -0.35 and a beta of 5.57. The stock has a fifty day simple moving average of $0.71 and a 200-day simple moving average of $0.91. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24.

Insider Activity

In related news, CEO Grigorios Siokas acquired 257,334 shares of the business’s stock in a transaction that occurred on Friday, December 20th. The shares were acquired at an average cost of $0.58 per share, for a total transaction of $149,253.72. Following the completion of the purchase, the chief executive officer now directly owns 3,774,314 shares in the company, valued at $2,189,102.12. This trade represents a 7.32 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Georgios Terzis acquired 85,778 shares of Cosmos Health stock in a transaction that occurred on Friday, December 20th. The stock was bought at an average cost of $0.58 per share, with a total value of $49,751.24. Following the acquisition, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at approximately $421,812.54. This trade represents a 13.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 569,278 shares of company stock valued at $348,841. Insiders own 15.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.